Burning Rock Biotech (BNR) Revenue (2019 - 2025)

Burning Rock Biotech's Revenue history runs 7 years deep, the most recent figure standing at $18.1 million for Q4 2025.

• In Q4 2025, Revenue rose 4.62% year-over-year to $18.1 million; the TTM figure through Dec 2025 stood at $75.6 million (up 5.56% YoY), while the FY2025 annual figure was $77.2 million, up 9.18% from the prior year.
• Revenue was $18.1 million for Q4 2025 at Burning Rock Biotech, down from $18.5 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $23.1 million in Q4 2021 to a low of $16.3 million in Q1 2021.
• Historically, Revenue has averaged $19.2 million across 5 years, with a median of $19.1 million in 2022.
• The sharpest annual moves came in 2021 and 2023: Revenue jumped 68.69% in 2021, then slipped 19.56% in 2023.
• A 5-year view of Revenue shows it stood at $23.1 million in 2021, then decreased by 10.81% to $20.6 million in 2022, then retreated by 17.3% to $17.1 million in 2023, then gained by 1.24% to $17.3 million in 2024, then gained by 4.62% to $18.1 million in 2025.
• The last three Revenue figures came in at $18.1 million (Q4 2025), $18.5 million (Q3 2025), and $20.7 million (Q2 2025), per Business Quant data.